Design and synthesis of new potent, silent 5-HT(1A) antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 23, 1998, Pages 3423-3428

  Perez, M ^a   Pauwels, P J ^a   Pallard Sigogneau, I ^a   Fourrier, C ^a   Chopin, P ^a   Palmier, C ^a   Colovray, V ^a   Halazy, S ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; MILNACIPRAN; NORFLUOXETINE; PAROXETINE; PENBUTOLOL; PINDOLOL; PROPRANOLOL; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; DRUG CONFORMATION; DRUG DESIGN; DRUG POTENCY; DRUG POTENTIATION; DRUG SYNTHESIS; SEROTONIN UPTAKE; STRUCTURE ACTIVITY RELATION;

EID: 0032403624     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00619-2     Document Type: Article

References (20)

1. 1. Artigas, F. ; Ferez, V. Alvarez, E. Arch Gen Psychiatry 1994, 57, 248-251.
2. 2. Artigas, F.; Romero, L.; De Montigny, C. Blier, P. TINS 1996, 19, 378-383.
3. 3. Blier, P.; De Montigny, C. m/s 1997, 4, 519-526.
4. 4. Gardier, A.M.; Malagie, I.; Trillat, A.C.; Jacquot, C. Artigas, F. Fundam Clin Pharmacol 1996, 10, 16-27.
5. 5. Hjorth, S.; Auerbach, S.B. Behavioural Brain Research 1996, 73, 281-283.
6. 6. Cliffe, I.A.; Fletcher, A. Drugs of the Future 1993, 18, 631-642.
7. 7. De Jonghe, F.; Swinkels, J. CNS Drugs 1997, 7, 452-467.
8. 8. Montgomery, S.A.; Prost, J.F.; Solles, A. Briley, M. Int Clin Psychopharmacol 1996, 11 (suppl 4), 47-51.
9. 9. Kawanishi, Y.; Ishihara, S.; Tsushima, T.; Seno, K.; Miyagoshi, M.; Hagishita, S.; Ishikawa, M.; Shima, N.; Shimamura, M. Ishihara, Y. Bioorg Med Chem Lett 1996, 6, 1421-1426.
10. 10. Klunder, J.M.; Onami, T. Sharpless, K.B. J Org Chem 1989, 54, 1295-1304.
11. 11. Mitchell, D.; Koenig, T.M. Syn Comm 1995, 25, 1231-1238.
12. 12. Chiral HPLC study of compound 7a showed that the reaction between racemic mixture of amine 4b with racemic mixture of epoxide 15 gave 4 stereoisomers in equal amounts. Hence, the other reactions were assumed to give similar mixtures.
13. 13. Bonnaud, B.; Cousse, H.; Mouzin, G.; Briley, M.; Stenger, A.; Fauran, F. Couzinier, J.-P. J. Med Chem 1987, 30, 318-325.
14. 14. All new compounds gave satisfactory microanalytical and spectral data. Optical rotations were measured in methanol, at 25°C for compounds 7b (+ 12.4°); 7c (-5.2°); 9a (-51.7°); 9b (-34.2°); 10a (-7.4°); 10b (+ 10.2°). Milnacipran 6 used to prepare compound 8 is a mixture of enantiomers.
15. 15. Pauwels, P.J.; Van Gompel, P. Leysen, J.E. Biochem Pharmacol 1993, 45, 375-383.
16. 16. Pauwels, P.J.; Tardif, S.; Wurch, T. Colpaert, F.C. Naunyn-Schmiedeberg's Arch Pharmacol 1997, 356, 551-561.
17. 17. Clifford, E.M.; Gartside, S.E.; Umbers, V.; Cowen, P.J.; Hajos, M. Sharp, T. Br J Pharmacol 1998, 124, 206-212.
18. 18. Forster, E.A.; Cliffe, I.A.; Bill, D.J.; Dover, G.M.; Jones, D.; Reilly, Y. Fletcher, A. Eur J Pharmacol 1995, 287, 81-88.
19. 19. Liau, L.M.; Sleight, A.J.; Pitha, J. Peroutka, S.J. Pharmacology Biochemistry & Behavior 1991, 38, 555-559.
20. 20. Porsolt, R.D.; Bertin, A. Jaffre, M. Arch Int Pharmacodyn 1977, 229, 327-336.